PMC:7376974 / 7640-8103
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T20 | 34-42 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
| T21 | 71-78 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
| T22 | 104-116 | Body_part | denotes | cell surface | http://purl.org/sig/ont/fma/fma67653 |
| T23 | 104-108 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T24 | 192-200 | Body_part | denotes | proteins | http://purl.org/sig/ont/fma/fma67257 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 59 | 137-144 | Disease | denotes | rupture | MESH:D012421 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T58 | 104-108 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T59 | 148-155 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
| T60 | 247-254 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | viruses |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T36 | 34-42 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T37 | 71-78 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T38 | 192-200 | Chemical | denotes | proteins | http://purl.obolibrary.org/obo/CHEBI_36080 |
| T39 | 303-319 | Chemical | denotes | antiviral agents | http://purl.obolibrary.org/obo/CHEBI_22587 |
| T40 | 342-353 | Chemical | denotes | application | http://purl.obolibrary.org/obo/CHEBI_33232 |
| T41 | 384-394 | Chemical | denotes | inhibitors | http://purl.obolibrary.org/obo/CHEBI_35222 |
LitCovid-PD-GO-BP
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T16 | 71-88 | http://purl.obolibrary.org/obo/GO_0018158 | denotes | protein oxidation |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T51 | 168-320 | Sentence | denotes | These strategies target proteins and mechanisms of entry common in most of the viruses, thus allowing the preparation of wide spectrum antiviral agents. |
| T52 | 321-428 | Sentence | denotes | In this section, the application of different HNMs as powerful inhibitors of viral entry will be discussed. |